Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.400
+0.045 (1.03%)
Jun 25, 2026, 10:10 AM CET
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.57 billion as of June 24, 2026. Its market cap has increased by 89.97% in one year.
Market Cap
1.57B
Enterprise Value
1.56B
Revenue
839.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.40
Market Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.57B, an increase of 237.29%. That is a compound annual growth rate of 50.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 1.57B | -15.34% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.99B |
| Nykode Therapeutics AS | 1.05B |
| ArcticZymes Technologies ASA | 1.03B |
| Lytix Biopharma ASA | 715.17M |
| Zelluna ASA | 558.86M |
| SoftOx Solutions AS | 281.10M |
| Oncoinvent ASA | 219.44M |
| Arctic Bioscience AS | 88.96M |